Skip to content
value.today

Alkermes plc. vs Immunovant, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Alkermes plc. and Immunovant, Inc. are worth about the same: $6.7 B and $6.6 B (market caps of Oct 14, 2026 for Alkermes plc. and Oct 7, 2026 for Immunovant, Inc.).
  • Alkermes plc. made a net profit of $242 M, while Immunovant, Inc. made a net loss of $506 M.
  • Alkermes plc. employs more people: 2,050 against 70 at Immunovant, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02404807209602020202120222023202420252026Alkermes plc. 214Immunovant, Inc. 738

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$1B$1B$2B201720182019202020212022202320242025Alkermes plc. $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAlkermes plc.
ALKS · #2,908 in the world
Immunovant, Inc.
IMVT · #2,921 in the world
Profile
Country🇮🇪 Ireland🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded19872018
Size
Market cap$6.7 B$6.6 B
Revenue$1.5 B—
Net income$242 M▲ best$-506 M
Employees2,05070
Valuation
Price to sales3.8×—
Price to book3.7×7.8×
Free cash flow yield7.2%▲ best-6.1%
Profitability
Gross margin86.7%—
Operating margin17.2%—
Net margin16.4%—
Return on equity14.7%▲ best-64.8%
Return on invested capital14.7%—
Growth
Revenue growth-5.3%—
Revenue growth, 3 years a year9.9%—
Earnings per share growth-34.1%—
Financial strength
Debt to equity0.0×—
Net debt to EBITDA-1.4×—
Cash
Free cash flow margin32.5%—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Alkermes plc. or Immunovant, Inc.?

Alkermes plc. and Immunovant, Inc. are worth about the same: $6.7 B and $6.6 B (market caps of Oct 14, 2026 for Alkermes plc. and Oct 7, 2026 for Immunovant, Inc.).

Which makes more money, Alkermes plc. or Immunovant, Inc.?

Alkermes plc. made a net profit of $242 M, while Immunovant, Inc. made a net loss of $506 M.

Which has more employees, Alkermes plc. or Immunovant, Inc.?

Alkermes plc. employs more people: 2,050 against 70 at Immunovant, Inc.